Johnson & Johnson has fought a bid by plaintiffs to unseal millions of documents that have been produced in connection with the multidistrict product liability litigation over popular birth control patch Ortho Evra, arguing that the public dissemination of the information would prejudice the jury pool and cause “confusion and alarm” among patients.
In the ongoing bankruptcy proceedings of Marcal Paper Mills Inc., a coalition of companies has filed an objection to a recent $3 million proposed settlement agreement between Marcal and the U.S. Environmental Protection Agency over pollution claims involving New Jersey's Lower Passaic River.
Industrial conglomerate Tyco International Ltd. has blasted a bid by New Jersey authorities to amend an already amended complaint of securities fraud, saying enough is enough.
Novartis International AG has sued Ranbaxy Laboratories Limited, looking to stave off generic competition in the multibillion dollar market for the hypertension treatment Diovan, which Novartis touts as the world's leading branded high blood pressure medication.
Johns Hopkins University and Arrow International Inc. won a permanent injunction Thursday that will stop Datascope Corp. from selling a device that clears blood clots from vascular grafts in hemodialysis patients.
A federal judge on Thursday struck down the claims of a group of plaintiffs that last year opted out of the settlement of an antitrust class action against makers of electrical carbon products.
The mortgage unit of Friedman, Billings, Ramsay Group Inc. has paid $14 million to settle two putative class actions brought by employees who claimed they were denied overtime wages and meal breaks in violation of federal labor laws.
After being chided for his “mind-numbing contentiousness,” an attorney for technology outsourcing company Infocrossing Inc. has asked a district judge to overturn orders which limited his discovery attempts in a patent case against Sandata Technologies over healthcare worker monitoring systems.
Novartis has lashed out at a bid by two plaintiffs in the Aredia and Zometa litigation over their bid to sanction the pharmaceutical company for refusing to remand their cases to state court, arguing that recent case law warrants that the court deny the plaintiffs’ remand request.
Mutual fund firm Franklin Resources Inc. on Friday asked the court to extend the deadline for responding to a class action complaint which accuses the company of offering kickbacks to brokers and dealers for pushing its funds onto unwitting investors.
A proposed class action has been filed in a California state court against a Chinese pet food manufacturer and its U.S.-based distributor in a bid to recover damages from alleged injuries to pet owners whose dogs and cats became sick or died from ingesting melamine.
High-profile class action law firm Milberg Weiss Bershad & Schulman will go to trial early next year on charges it bribed clients to act as lead plaintiffs in securities suits for over 20 years, a judge ruled Monday.
SBC Bank and Getzler Henrich & Associates LLC have sought to prevent expert testimony and to limit the admissibility of evidence suggesting that they owe wages and pension plan contributions to the plaintiffs.
After a judge dismissed many of their counts against the company in June, New Jersey-based plaintiffs suing Tyco International for securities fraud are continuing their effort to stay the case by joining an earlier motion to force Tyco to hand over contested documents.
Lloyds TSB Bank PLC is fighting a bid by Moody's Investors Service Inc. to dismiss claims that the company violated securities laws in a case that falls under the umbrella of the multidistrict litigation related to National Century Financial Services Inc.'s 2002 collapse.
A group of plaintiffs are turning on their well-paid lawyers, suing two high-profile class action firms over an alleged scheme to win the coveted lead counsel trophy by bribing clients to serve as class representatives.
A small financial information aggregator has accused that market's giant, Bankrate Inc., of a laundry list of antitrust violations, including predatory pricing, engaging in illegal mergers, and seeking and maintaining a monopoly.
Drug development services company PharmaNet Development Group Inc.—formerly known as SFBC International Inc.—has agreed to settle consolidated shareholder derivative litigation that related allegations of rampant nepotism, unethical clinical testing practices and unsafe conditions at the company's flagship testing facility.
A judge has approved the disclosure statement of bankrupt Kara Homes Inc. now that the company has come to terms with those who objected, a move that inches the company closer to emerging from Chapter 11 protection.
A state appellate court ruled on Wednesday that 98 British plaintiffs could not sue pharmaceutical giant Merck & Co. in a New Jersey state court, saying that British citizens who had suffered heart attacks after taking Merck's drug Vioxx must take their cases to the United Kingdom.